Weon Kim

发表

Effects of Fixed-Dose Combination of Low-Intensity Rosuvastatin and Ezetimibe Versus Moderate-Intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-Blind, Multicenter, Phase III Study.

T. Hong, Jung‐Sun Kim, T. Kang, 2021, Clinical therapeutics.

Efficacy and Safety of Da-Chai-Hu-Tang in Lipid Profiles in High-Risk, Statin-Treated Patients with Residual HyperTG: A 12-Week, Randomized, Active-Control, Open Clinical Study

J. Woo, Hyemoon Chung, Jung-Myung Lee, 2022, Life.

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study

K. Sung, Sungha Park, Sang-Wook Lim, 2020, Drug design, development and therapy.

A Paradigm Shift in Dyslipidemia Management in Primary Care: A 12-Month Cohort Study.

Jaehyuk Choi, W. Shin, H. Kim, 2022, Clinical therapeutics.

A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monothe

Y. Ahn, Sang-Wook Lim, D. Kim, 2018, Medicine.

Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy

J. Chae, S. Baek, B. Oh, 2015, Drug design, development and therapy.

Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial

K. Sung, J. Sung, Yong-Jin Kim, 2022, The Journal of Clinical Hypertension.

A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hyperch

K. Sung, D. Cha, Hyo‐Soo Kim, 2018, Clinical therapeutics.

Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)

Y. Ahn, T. Hong, Sungha Park, 2016, Cardiovascular therapeutics.

Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study.

T. Hong, B. Hong, Kiyuk Chang, 2019, Clinical therapeutics.

Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia.

Y. Yoon, K. Sung, S. Han, 2018, Clinical therapeutics.

A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia

Min Chul Kim, T. Hong, Sang-Hyun Kim, 2023, American Journal of Cardiovascular Drugs.